X4 Pharmaceuticals, Inc (XFOR) › Net IncomeX4 Pharmaceuticals, Inc (XFOR) — Net IncomeAnnual figures by fiscal year, from SEC filings.2016: -$22.98M2017: -$21.99M2018: -$33.28M2019: -$52.81M2020: -$62.13M2021: -$88.70M2022: -$93.87M2023: -$101.17M2024: -$37.45M2025: -$79.20M-$79.20M2016Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$79.20M-111.5%2024-$37.45M+63.0%2023-$101.17M-7.8%2022-$93.87M-5.8%2021-$88.70M-42.8%2020-$62.13M-17.7%2019-$52.81M-58.7%2018-$33.28M-51.3%2017-$21.99M+4.3%2016-$22.98M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share